- Home
- AMST vs EDSA Comparison
AMST vs EDSA Comparison
Compare AMST & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- EDSA
- Stock Information
- Founded
- AMST 2017
- EDSA 2015
- Country
- AMST United States
- EDSA Canada
- Employees
- AMST N/A
- EDSA N/A
- Industry
- AMST Computer Software: Prepackaged Software
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- EDSA Health Care
- Exchange
- AMST Nasdaq
- EDSA Nasdaq
- Market Cap
- AMST 7.4M
- EDSA 6.0M
- IPO Year
- AMST 2020
- EDSA N/A
- Fundamental
- Price
- AMST $4.41
- EDSA $1.91
- Analyst Decision
- AMST
- EDSA Strong Buy
- Analyst Count
- AMST 0
- EDSA 1
- Target Price
- AMST N/A
- EDSA $21.00
- AVG Volume (30 Days)
- AMST 47.6K
- EDSA 33.2K
- Earning Date
- AMST 02-12-2025
- EDSA 12-13-2024
- Dividend Yield
- AMST N/A
- EDSA N/A
- EPS Growth
- AMST N/A
- EDSA N/A
- EPS
- AMST N/A
- EDSA N/A
- Revenue
- AMST $114,798.00
- EDSA N/A
- Revenue This Year
- AMST N/A
- EDSA N/A
- Revenue Next Year
- AMST N/A
- EDSA N/A
- P/E Ratio
- AMST N/A
- EDSA N/A
- Revenue Growth
- AMST N/A
- EDSA N/A
- 52 Week Low
- AMST $1.85
- EDSA $1.55
- 52 Week High
- AMST $6.27
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- AMST 57.94
- EDSA 45.42
- Support Level
- AMST $4.19
- EDSA $1.65
- Resistance Level
- AMST $5.18
- EDSA $1.91
- Average True Range (ATR)
- AMST 0.53
- EDSA 0.17
- MACD
- AMST -0.01
- EDSA 0.04
- Stochastic Oscillator
- AMST 25.69
- EDSA 79.02
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.